Zymeworks Inc. (ZYME)

Zymeworks Inc. (ZYME) is a healthcare company (biotechnology) based in the United States. The share price is $25.84, down 2.31% on the day, which values the company at $1.81B. Price as of 18 Nov 2026, 10:38 UTC, from Yahoo Finance.

Key facts

Share price
$25.84−2.31% today
Market value
$1.81B
P/E ratio
48.8×last 12 months
Forward P/E
87.1×
Funk Score
42/100
Against its own history
Well above its usual priceusual price $17.67
200-week average
$14.8574% above
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Zymeworks Inc. in more detail

ZYME trades at 48.8× its last twelve months' earnings, 87.1× next year's expected earnings, 6.8× sales. Measured against its own history, the price is 46% above what its usual multiples would imply ($17.67) — well above its usual price. It sits 74% above its 200-week average of $14.85.

Over the last five fiscal years Zymeworks Inc. has compounded revenue 22.2% a year. Its Funk Score is 42 out of 100 (financial strength 8.8, profitability 2.3, growth 5.3, value 0.2, each out of 10).

In its favour: Altman Z in the safe zone; More cash than debt. Worth checking: Heavy stock-based pay.

Zymeworks Inc. (ZYME): questions and answers

What is ZYME's P/E ratio?

Zymeworks Inc. trades at 48.8× its last twelve months' earnings and 87.1× next year's expected earnings.

What is Zymeworks Inc.'s market cap?

Zymeworks Inc. is valued at $1.81B at a share price of $25.84.

Is ZYME overvalued or undervalued?

Against its own history, ZYME is well above its usual price: the price is 46% above the $17.67 implied by the median multiples it has traded at (price / sales, price / book). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is ZYME above its 200-week moving average?

Yes. ZYME is 74.0% above its 200-week average of $14.85. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is Zymeworks Inc. growing?

Over the last five fiscal years Zymeworks Inc.'s revenue grew 22.2% a year.

Does ZYME pay a dividend?

Zymeworks Inc. does not currently pay a regular dividend.

Cite this page

Funkfolio, “Zymeworks Inc. (ZYME) stock: price, valuation and fundamentals”, data as of 18 November 2026. https://funkfolio.com/stock/ZYME

Underlying data: Yahoo Finance; company filings with the SEC.